Your browser doesn't support javascript.
loading
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
Garfall, Alfred L; Stadtmauer, Edward A; Hwang, Wei-Ting; Lacey, Simon F; Melenhorst, Jan Joseph; Krevvata, Maria; Carroll, Martin P; Matsui, William H; Wang, Qiuju; Dhodapkar, Madhav V; Dhodapkar, Kavita; Das, Rituparna; Vogl, Dan T; Weiss, Brendan M; Cohen, Adam D; Mangan, Patricia A; Ayers, Emily C; Nunez-Cruz, Selene; Kulikovskaya, Irina; Davis, Megan M; Lamontagne, Anne; Dengel, Karen; Kerr, Naseem Ds; Young, Regina M; Siegel, Donald L; Levine, Bruce L; Milone, Michael C; Maus, Marcela V; June, Carl H.
Affiliation
  • Garfall AL; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Stadtmauer EA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Hwang WT; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lacey SF; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Melenhorst JJ; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Krevvata M; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Carroll MP; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Matsui WH; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wang Q; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dhodapkar MV; Yale University School of Medicine, New Haven, Connecticut, USA.
  • Dhodapkar K; Yale University School of Medicine, New Haven, Connecticut, USA.
  • Das R; Yale University School of Medicine, New Haven, Connecticut, USA.
  • Vogl DT; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Weiss BM; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Cohen AD; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Mangan PA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ayers EC; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Nunez-Cruz S; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kulikovskaya I; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Davis MM; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lamontagne A; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dengel K; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kerr ND; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Young RM; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Siegel DL; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Levine BL; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Milone MC; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Maus MV; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • June CH; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
JCI Insight ; 3(8)2018 04 19.
Article in En | MEDLINE | ID: mdl-29669947

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Immunotherapy, Adoptive / Antigens, CD19 / Melphalan / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JCI Insight Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Immunotherapy, Adoptive / Antigens, CD19 / Melphalan / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JCI Insight Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States